αO-Conotoxin GeXIVA Inhibits the Growth of Breast Cancer Cells via Interaction with α9 Nicotine Acetylcholine Receptors

The α9-containing nicotinic acetylcholine receptor (nAChR) is increasingly emerging as a new tumor target owing to its high expression specificity in breast cancer. αO-Conotoxin GeXIVA is a potent antagonist of α9α10 nAChR. Nevertheless, the anti-tumor effect of GeXIVA on breast cancer cells remains...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Zhihua Sun, Jiaolin Bao, Manqi Zhangsun, Shuai Dong, Dongting Zhangsun, Sulan Luo
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2020-04-01
Sarja:	Marine Drugs
Aiheet:	α9-nicotinic acetylcholine receptors (nAChRs) breast cancer cells αO-conotoxin GeXIVA apoptosis anti-proliferation targeted therapy
Linkit:	https://www.mdpi.com/1660-3397/18/4/195
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!